期刊
JOURNAL OF CARDIOVASCULAR MEDICINE
卷 13, 期 7, 页码 443-453出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.2459/JCM.0b013e328354e3ac
关键词
atherosclerosis; cardiovascular disease; paraoxonase 1; PON1 polymorphisms; PON1 status
资金
- Cape Peninsula University of Technology
- University of Stellenbosch
- Medical Research Council (MRC) of South Africa
The wide acceptance of the oxidation theory of atherogenesis has prompted attention to antioxidant mechanisms, particularly the prevention of lipid oxidation by high-density lipoprotein-associated proteins like paraoxonase 1 (PON1) enzyme. PON1 is a calcium-dependent enzyme that has interested toxicologists since its discovery as an organophosphate hydrolase. There is a growing interest in the enzyme's importance in cardiovascular health prompted by evidence that it may have a role in lipid metabolism and the development of atherosclerosis via its antioxidant effects. PON1 is capable of hydrolyzing homocysteine thiolactone, a metabolite of homocysteine that can impair protein function leading to endothelial dysfunction and vascular damage. Although this lactonase activity has been suggested to be PON1's native activity, the enzyme's specific physiological role and substrate remain unclear. In this review, we summarize developments in the field of PON1 research relating to cardiovascular health, and highlight those that perhaps warrant further research. J Cardiovasc Med 2012, 13:443-453
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据